Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
April 21, 2016

M&As this week: Chongqing Sansheng, Recipharm

Building materials and chemicals company Chongqing Sansheng has revealed its plans to take over a pharmaceutical company also based in China.

Kemwell Biopharma

Building materials and chemicals company Chongqing Sansheng has revealed its plans to take over a pharmaceutical company also based in China.

Named Liaoyun City Baikang Pharmaceutical, the target company was previously known as Liaoyuan First Pharmaceutical Factory.

The final deal consideration of the acquisition is estimated to be $40.13m.

Recipharm has announced its plan to acquire certain businesses of Kemwell Biopharma.

"The final deal consideration of the acquisition is estimated to be $40.13m."

The sale consideration for the takeover is $205.86m, which will be entirely arranged by Recipharm through various means.

Legal advisors to the transaction are Veritas Legal Services, CalissendroffSwarting Advokatbyra KB, and Obermayer Rebmann Maxwell & Hippel LLP.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining

PWC Capital is the financial adviser to Recipharm, on the transaction.


Image: Recipharm has announced its plan to acquire certain businesses of Kemwell Biopharma; Photo: courtesy of Kemwell Biopharma.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU